316 related articles for article (PubMed ID: 31469400)
21. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
Sun M; Sammon JD; Becker A; Roghmann F; Tian Z; Kim SP; Larouche A; Abdollah F; Hu JC; Karakiewicz PI; Trinh QD
BJU Int; 2014 Feb; 113(2):200-8. PubMed ID: 23937636
[TBL] [Abstract][Full Text] [Related]
22. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
23. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.
Nam RK; Cheung P; Herschorn S; Saskin R; Su J; Klotz LH; Chang M; Kulkarni GS; Lee Y; Kodama RT; Narod SA
Lancet Oncol; 2014 Feb; 15(2):223-31. PubMed ID: 24440474
[TBL] [Abstract][Full Text] [Related]
24. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
Jeldres C; Cullen J; Hurwitz LM; Wolff EM; Levie KE; Odem-Davis K; Johnston RB; Pham KN; Rosner IL; Brand TC; L'Esperance JO; Sterbis JR; Etzioni R; Porter CR
Cancer; 2015 Jul; 121(14):2465-73. PubMed ID: 25845467
[TBL] [Abstract][Full Text] [Related]
25. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
Herlemann A; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2018 Feb; 73(2):215-223. PubMed ID: 28499617
[TBL] [Abstract][Full Text] [Related]
26. Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.
Capogrosso P; Vertosick EA; Benfante NE; Eastham JA; Scardino PJ; Vickers AJ; Mulhall JP
Eur Urol; 2019 Feb; 75(2):221-228. PubMed ID: 30237021
[TBL] [Abstract][Full Text] [Related]
27. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
28. The 4Kscore Predicts the Grade and Stage of Prostate Cancer in the Radical Prostatectomy Specimen: Results from a Multi-institutional Prospective Trial.
Punnen S; Nahar B; Prakash NS; Sjoberg DD; Zappala SM; Parekh DJ
Eur Urol Focus; 2017 Feb; 3(1):94-99. PubMed ID: 28720374
[TBL] [Abstract][Full Text] [Related]
29. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
[TBL] [Abstract][Full Text] [Related]
30. Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.
Degeling K; Corcoran NM; Pereira-Salgado A; Hamid AA; Siva S; IJzerman MJ
Value Health; 2021 Dec; 24(12):1737-1745. PubMed ID: 34838271
[TBL] [Abstract][Full Text] [Related]
31. Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.
Kobayashi T; Kanao K; Araki M; Terada N; Kobayashi Y; Sawada A; Inoue T; Ebara S; Watanabe T; Kamba T; Sumitomo M; Nasu Y; Ogawa O
Int J Clin Oncol; 2018 Apr; 23(2):347-352. PubMed ID: 29127531
[TBL] [Abstract][Full Text] [Related]
32. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
33. Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy.
Gardner TA; Bissonette EA; Petroni GR; McClain R; Sokoloff MH; Theodorescu D
Cancer; 2000 Jul; 89(2):424-30. PubMed ID: 10918175
[TBL] [Abstract][Full Text] [Related]
34. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
[TBL] [Abstract][Full Text] [Related]
36. Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G; De Luca S; Oderda M; Munoz F; Krengli M; Allis S; Baima CG; Barale M; Bartoncini S; Beldì D; Bellei L; Bellissimo AR; Bernardi D; Biamino G; Billia M; Borsa R; Cante D; Castelli E; Cattaneo G; Centrella D; Collura D; Coppola P; Dalmasso E; Di Stasio A; Fasolis G; Fiorio M; Garibaldi E; Girelli G; Griffa D; Guercio S; Migliari R; Molinaro L; Montefiore F; Montefusco G; Moroni M; Muto G; Ponti di Sant'Angelo F; Ruggiero L; Ruo Redda MG; Serao A; Squeo MS; Stancati S; Surleti D; Varvello F; Volpe A; Zaramella S; Zarrelli G; Zitella A; Bollito E; Gontero P; Porpiglia F; Galassi C; Bertetto O;
JAMA Netw Open; 2023 Oct; 6(10):e2338039. PubMed ID: 37847502
[TBL] [Abstract][Full Text] [Related]
37. Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study.
Matta R; Hird AE; Dvorani E; Saskin R; Nason GJ; Kulkarni G; Kodama RT; Herschorn S; Nam RK
Cancer Med; 2020 Oct; 9(19):6946-6953. PubMed ID: 32757442
[TBL] [Abstract][Full Text] [Related]
38. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database.
Vesey SG; McCabe JE; Hounsome L; Fowler S
BJU Int; 2012 Feb; 109(3):346-54. PubMed ID: 21771246
[TBL] [Abstract][Full Text] [Related]
39. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.
Evans SM; Millar JL; Frydenberg M; Murphy DG; Davis ID; Spelman T; Bolton DM; Giles GG; Dean J; Costello AJ; Frauman AG; Kearns PA; Day L; Daniels C; McNeill JJ
BJU Int; 2014 Nov; 114(5):680-90. PubMed ID: 24128010
[TBL] [Abstract][Full Text] [Related]
40. Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.
Hong SK; Sternberg IA; Keren Paz GE; Kim PH; Touijer KA; Scardino PT; Eastham JA
Eur Urol; 2014 Aug; 66(2):214-9. PubMed ID: 23954083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]